Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resistant Potato Starch for Gut MDRO Decolonization
NCT07792915Phase 2Not yet recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Jan 2027
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
A Phase 2 trial of resistant potato starch in Clostridial infection, methicillin-resistant Staphylococcus aureus infection (MRSA), enterococcal infection, Carbapenem-resistant Enterobacteriaceae (CRE), asymptomatic infection, sponsored by VA Office of Research & Development. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
resistant potato starch
03
Conditions
Clostridial infectionmethicillin-resistant Staphylococcus aureus infection (MRSA)enterococcal infectionCarbapenem-resistant Enterobacteriaceae (CRE)asymptomatic infection
Beyond the preview
Go deeper on NCT07792915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07792915.